Oncology Central

Zinc isotopes: a novel approach to biomarkers of breast cancer?


Biomarkers for cancer are essential for diagnosis, prognosis and for predicting the response to specific treatments. Each biomarker has a degree of specificity and sensitivity. For example, estrogen receptors are good biomarkers for breast carcinomas, but there are breast cancers that are estrogen receptor negative, and there are other tumors, e.g., ovarian cancers, which are estrogen receptor positive.

To view restricted content, please:



News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.